Overview
Nephropathic cystinosis is a rare, inherited autosomal recessive disorder characterized by the accumulation of cystine in lysosomes, leading to multi-system involvement including renal failure, endocrine dysfunction, and neurological complications 24.Diagnosis
Early diagnosis through family history and genetic testing 2.
Monitoring of white blood cell (WBC) cystine levels to assess cysteamine efficacy 2.
Histopathological and immunohistochemical studies for extra-renal manifestations, such as corneal and conjunctival changes 3.
Neurological evaluation and imaging (e.g., cerebral atrophy on CT) for central nervous system involvement 4.Management
First-line treatment: Cysteamine therapy to reduce cystine accumulation; dosage and monitoring by WBC cystine levels 2.
Adjunctive treatments:
- Growth hormone for growth retardation 2.
- Renal transplantation for end-stage renal failure 2.
- Hormone replacement therapy for endocrine deficiencies (e.g., thyroid, adrenal, gonadal) 24.
- Management of complications such as portal hypertension and splenomegaly 2.Special Populations
Pediatrics: Early initiation of cysteamine therapy and regular monitoring of WBC cystine levels crucial 2.
Adults: Surveillance for multi-organ dysfunction including neurological, endocrine, and cardiovascular systems 4.Key Recommendations
Regular monitoring of WBC cystine levels to ensure effective cysteamine therapy (Evidence: Strong 2).
Initiate cysteamine therapy early in life and consider growth hormone for growth retardation (Evidence: Strong 2).
Screen for and manage extra-renal manifestations, including endocrine deficiencies and neurological symptoms, in patients with nephropathic cystinosis (Evidence: Moderate 24).
Be vigilant for fibrosing colonopathy as a potential adverse effect of cysteamine delayed-release capsules, especially monitoring for non-specific symptoms (Evidence: Weak 1).References
1 Kishk OA, Kim I, Cheng C, Summan M, Muñoz MA. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric nephrology (Berlin, Germany) 2024. link
2 Besouw MT, Van Dyck M, Cassiman D, Claes KJ, Levtchenko EN. Management dilemmas in pediatric nephrology: Cystinosis. Pediatric nephrology (Berlin, Germany) 2015. link
3 Kaiser-Kupfer MI, Chan CC, Rodrigues M, Datiles MB, Gahl WA. Nephropathic cystinosis: immunohistochemical and histopathologic studies of cornea, conjunctiva and iris. Current eye research 1987. link
4 Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H. Nephropathic cystinosis with central nervous system involvement. The American journal of medicine 1987. link90661-9)